Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel de Groot

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Channels (Austin, Tex.)|June 10, 2011
Dissecting TRPV1: lessons to be learned?Christian Grimm, Eduardo Aneiros, Marcel de Groot
Bioorganic & Medicinal Chemistry Letters|April 15, 2017
Discovery of LRRK2 inhibitors by using an ensemble of virtual screening methodsEmanuela Gancia, Marcel De Groot, Brenda Burton, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2006
Overcoming HERG affinity in the discovery of the CCR5 antagonist maravirocDavid A Price, Duncan Armour, Marcel de Groot, et al.
Current Topics in Medicinal Chemistry|September 11, 2008
Overcoming hERG affinity in the discovery of maraviroc; a CCR5 antagonist for the treatment of HIVDavid A Price, Duncan Armour, Marcel de Groot, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013
Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channelsKen McCormack, Sonia Santos, Mark L Chapman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Channels (Austin, Tex.)|June 10, 2011
Dissecting TRPV1: lessons to be learned?Christian Grimm, Eduardo Aneiros, Marcel de Groot
Bioorganic & Medicinal Chemistry Letters|April 15, 2017
Discovery of LRRK2 inhibitors by using an ensemble of virtual screening methodsEmanuela Gancia, Marcel De Groot, Brenda Burton, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2006
Overcoming HERG affinity in the discovery of the CCR5 antagonist maravirocDavid A Price, Duncan Armour, Marcel de Groot, et al.
Current Topics in Medicinal Chemistry|September 11, 2008
Overcoming hERG affinity in the discovery of maraviroc; a CCR5 antagonist for the treatment of HIVDavid A Price, Duncan Armour, Marcel de Groot, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013
Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channelsKen McCormack, Sonia Santos, Mark L Chapman, et al.
Pageof 1